Trial Outcomes & Findings for Fresh Versus Old Red Blood Cells for Transfusion (NCT NCT01319552)

NCT ID: NCT01319552

Last Updated: 2015-06-02

Results Overview

Comparison of increase in non-transferrin-bound iron for each participant between his or her "fresh" and "old" blood transfusion four hours after transfusion.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

14 participants

Primary outcome timeframe

four hours after transfusion

Results posted on

2015-06-02

Participant Flow

The recruitment of volunteers began in December 2008 and ended in October 2010. All the volunteers were recruited at Columbia University.

Participant milestones

Participant milestones
Measure
Transfusion
Fresh transfusion : 1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions followed by old transfusion : 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
Overall Study
STARTED
14
Overall Study
COMPLETED
14
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Fresh Versus Old Red Blood Cells for Transfusion

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Transfusion
n=14 Participants
Fresh transfusion: 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions 1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions Old transfusion: 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
n=99 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
Sex: Female, Male
Female
4 Participants
n=99 Participants
Sex: Female, Male
Male
10 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
2 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
Race (NIH/OMB)
White
11 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United States
14 participants
n=99 Participants

PRIMARY outcome

Timeframe: four hours after transfusion

Comparison of increase in non-transferrin-bound iron for each participant between his or her "fresh" and "old" blood transfusion four hours after transfusion.

Outcome measures

Outcome measures
Measure
Fresh Transfusion
n=14 Participants
Fresh transfusion: 1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions
Old Transfusion
n=14 Participants
Old transfusion : 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
Measure of Non-transferrin-bound Iron
0.16 μM
Standard Deviation 0.99
3.17 μM
Standard Deviation 3.26

Adverse Events

Transfusion

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Transfusion
n=14 participants at risk
Fresh transfusion : 1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions followed by old transfusion : 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
Gastrointestinal disorders
Nausea
14.3%
2/14 • Number of events 2
Nervous system disorders
Headache
7.1%
1/14 • Number of events 1

Additional Information

Dr. Steven Spitalnik

Columbia University

Phone: 2123425648

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place